Advanced search
Publication Cover
Emerging Therapeutic Targets Volume 5, 2001 - Issue 2
Journal homepage
27
Views
3
CrossRef citations to date
0
Altmetric
Review

NF-κB: a therapeutic target in inflammatory diseases

Christine L Curran Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University, School of Medicine, T-1217 MCN, Nashville, TN 27232-2650, USA. [email protected]
,
Timothy S Blackwell Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University, School of Medicine, T-1217 MCN, Nashville, TN 27232-2650, USA. [email protected]
&
John W Christman Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University, School of Medicine, T-1217 MCN, Nashville, TN 27232-2650, USA. [email protected]
Pages 197-204 | Published online: 25 Feb 2005

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Irmgard Merfort. (2006) Patented inhibitors (2002 – 2005) of the transcription factor NF-κB. Expert Opinion on Therapeutic Patents 16:6, pages 797-810.
Read now

Articles from other publishers (2)

Job O. Mapesa, Nadine Waldschmitt, Ingrid Schmoeller, Carolin Blume, Thomas Hofmann, Symon Mahungu, Thomas Clavel & Dirk Haller. (2011) Catechols in caffeic acid phenethyl ester are essential for inhibition of TNF-mediated IP-10 expression through NF-κB-dependent but HO-1- and p38-independent mechanisms in mouse intestinal epithelial cells. Molecular Nutrition & Food Research 55:12, pages 1850-1861.
Crossref
Dominik Altevogt, Andrea Hrenn, Claudia Kern, Lilia Clima, Willi Bannwarth & Irmgard Merfort. (2009) A new assay format for NF-κB based on a DNA triple helix and a fluorescence resonance energy transfer. Organic & Biomolecular Chemistry 7:19, pages 3934.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.